A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery (NCT01224119) | Clinical Trial Compass
UnknownPhase 1/2
A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery
Canada24 participantsStarted 2011-01
Plain-language summary
The current research study evaluates an investigational medical device called Amplex B2A(TM) Peptide Enhanced Ceramic Granules ("Amplex") for use in foot and ankle fusion. Amplex is a synthetic bone graft material. The most frequently used graft material is bone collected from the patient (autograft). Autograft involves a secondary incision with the risks of infection and lasting pain.
The purpose of this study is to determine if Amplex is a safe and effective alternative to autograft.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Indicated for foot and ankle surgery described as either a single, double or triple arthrodesis of the ankle, subtalar, calcaneocuboid or talonavicular joints.
* Have the ability to understand the requirements of the study, to provide written informed consent, and to comply with the study protocol
* Have the ability to understand and provide written authorization for the use and disclosure of personal health information (PHI)
* Be a skeletally mature male or a non-pregnant, non-lactating female at least 18 years of age but not older than age 75
* If a woman is of childbearing potential (not amenorrheic for the previous 24 months or not surgically sterile), then she must:
* Have a confirmed negative urine pregnancy test result prior to surgery and the administration of the study product
* Agree to use a medically approved method of contraception for the duration of the initial follow-up period of the study
* Agree to participate in postoperative clinical and radiographic evaluations and comply with the required study regimen
* Have not been sufficiently responsive to an adequate trial of non-operative treatment (e.g. modified activity, analgesics, anti-inflammatories, bracing, orthotics, physiotherapy, vitamin supplements, or injections etc. prior to study enrollment).
Exclusion Criteria:
* Has a large bone deficit requiring a structural graft
* Charcot joints from neuropathic destruction.
* Previous fusion or osteotomy of the proposed site
* Requ…